New antiviral compound blocks Covid virus from entering cells: Study
The Hindu
The compound, described in the journal Proceedings of the National Academy of Sciences, targets a key human protein called transmembrane serine protease 2 (TMPRSS2) that coronaviruses harness to enter and infect human cells.
Scientists have developed a chemical compound that they say could prevent infection from SARS-CoV-2 virus or reduce the severity of COVID-19 if given early in the course of an infection.
The compound, called MM3122, interferes with a key feature of many viruses that allows them to invade human cells, according to the researchers at Washington University School of Medicine in the US.
The compound, described in the journal Proceedings of the National Academy of Sciences, targets a key human protein called transmembrane serine protease 2 (TMPRSS2) that coronaviruses harness to enter and infect human cells.
